6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
29m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
29m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
29m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
30m ago	First Quantum Minerals Reports First Quarter 2026 Results
30m ago	District Metals Announces $10 Million Private Placement Financing

About

Sab Biotherapeutics Inc (NASDAQ:SABS) — investor relations, events, news, and company updates on 6ix.

Latest News

SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026

SAB BIO to Present Additional Data Supporting the Unique Profile of SAB-142 at the 2026 Immunology of Diabetes Society Congress

SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants

SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants

SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Financials

Revenue

$114.7 K

Market Cap

$272.67 M

EPS

-0.79

Community Chat

Ask AI